期刊文献+

连续静脉-静脉血液滤过救治多脏器功能失常综合征 被引量:3

Treatment of multiple organ dysfunction syndrome by continuous venous-venous hemofiltration
在线阅读 下载PDF
导出
摘要 目的总结持续静脉-静脉血液滤过(CVVH)在多脏器功能失常综合征(MODS)中的治疗作用。方法CVVH治疗组为ICU中MODS患者31例,男19例,女12例,18-78岁,除给予常规治疗外,应用德国贝朗Diapact持续肾替代治疗机连续治疗48~72h,以后行每天8h的日间血滤,治疗时间共64~102h;同时35例MODS患者,男22例,女13例,年龄21~81岁,仅给予常规治疗。治疗期间监测生命体征,血常规,电解质,氧合指数(PO2/FIO2)。血糖,凝血功能,白蛋白(ALB),肌酐(CRE),尿素氮(BUN),C-反应蛋白(CRP),格拉斯哥评分(GSC),MODS评分,急性生理学和慢性健康评分Ⅱ(APACHEⅡ)。结果CVVH治疗组ICU7d转出率为100%,明显高于对照组(25.7%。P〈0.01),治疗组7d病死率为0,显著低于对照组(37.1%,P〈0.01),并且治疗组总的住院病死率为12.9%,明显低于对照组(48.6%,P〈0.01)。CVVH治疗后血清白蛋白、Na^+、氧分压(PO2)及GSC均显著高于治疗前(P〈0.01)。血清K^+、Ca^+、pH值、HCO^3-及PO2/FIO2滤过后均高于治疗前(均P〈0.05)。体温、呼吸频率、二氧化碳分压(PCO2)、BUN、CRE、CRP、APACHEⅡ/、MODS评分均显著低于治疗前(均P〈0.01)。治疗组心率、中心静脉压低于治疗前(均P〈0.05)。结论CVVH具有多器官功能支持治疗的功能,CVVH是治疗多脏器功能失常综合征的有效方法。 Objective To investigate the effects of continuous venous-venous hemofiltration (CVVH) in treatment of multiple organ dysfunction syndrome(MODS). Methods 31 patients with MODS, 19 males and 12 females, aged 18-78, underwent, in addition to routine treatment, CVVH with Braun Diapact continuous renal replacement therapy machine in ICU for 48-72 hours and then 8 h a day during daytime, with a total CVVH time of 64-102h; and 35 MODS patients, 22 males and 13 females, aged 21-81, underwent routine treatment only. During the treatment, the life signs, blood routine, electrolytes, hematopneic index (PO2/FIO2) , blood sugar, coagulation function, serum albumin (ALB), creatinine (CRE), blood urea nitrogen (BUN), C-reactive protein (CRP), Glasgow score (GSC), multiple organ dysfunction(MODS) score, and acute physiology and chronic health evaluation U (APACHE Ⅱ ) were monitored. Results The 7d ICU transfer rate of the CVVH group was 100%, significantly higher than that of the control group (25.7%, P〈0.01), the 7d ICU mortality of the CVVH group was 0, significantly lower than that of the control group (37.1%, P〈0.01), and the general in-hospital mortality of the CVVH group was 12.9%, significantly lower than that of the control group (48.6%, P〈0.01). The levels of serum ALB , Na^+, partial pressure of oxygen (PO2) and GSC after CVVH were all significantly higher than those before CVVH (all P〈0.01). The levels of serum K^+, Ca^2+, pH, HCO^3- and PO2/FIO2after CVVH were all higher than those before CVVH (all P〈0.05). The levels of body temperature, respiratory rate, PCO2 , BUN, CRE, CRP, APACHE Ⅱ , and MODS score after CVVH were all significantly lower than those before CVVH (all P〈0.01). The heart rate and CVP after CVVH was both lower than that before CVVH (both P〈0.05). Conclusion Effective in treatment of MODS, CVVH has the function of multiple organ support therapy.
出处 《中国急救复苏与灾害医学杂志》 2009年第12期965-968,共4页 China Journal of Emergency Resuscitation and Disaster Medicine
关键词 连续静脉—静脉血液滤过 多脏器功能失常综合征 Continuous venous-venous hemofiltration Multiple organ dysfunction syndrome
作者简介 王允野,副主任医师,研究方向:急性中毒及重症急性胰腺炎救治 通讯作者:张志博,132011吉林市中心医院ICU,E-mail:zhang@tom.com
  • 相关文献

参考文献6

二级参考文献74

  • 1季大玺.连续性血液净化与重症感染[J].肾脏病与透析肾移植杂志,2004,13(3):235-236. 被引量:58
  • 2黎磊石,刘志红.对连续性血液净化的认识在不断深化中[J].肾脏病与透析肾移植杂志,2004,13(5):451-452. 被引量:60
  • 3张红松,李培杰,陈天铎,杨兰,董晨明.血栓前体蛋白测定在严重脓毒症中的意义及干预治疗对其的影响[J].中国急救医学,2005,25(1):4-6. 被引量:5
  • 4Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovation therapies in sepsis[J].American College of Chest Physician/Society of Critical Care Medicine Consensus Conference Chest,1992,101 (6):1644-1655.
  • 5Mesters RM,Helterbrand J,Utterback BG,et al.Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications[J].Crit Care Med,2000,28:2209-2216.
  • 6Marcel Levi,Hugo ten Cate.Disseminated intravascular coagulation[J].N Engl J Med,1999,341:586-592.
  • 7[1]Evenepoel P, Maes B, Vanwalleghem J, et al. Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate [J]. Am J Kidney Dis,2002,39(2): 315-323.
  • 8[2]Tolwani AJ, Campbell RC, Schenk MB, et al. Simplified citrate anticoagulation for continuous renal replacement therapy [J]. Kidney Int, 2001,60(1): 370-374.
  • 9[6]Kutsogiannis DJ, Mayers I, Chin WD, et al. Regional citrate anticoagulation in continuous venovenous hemodiafiltration [J]. Am J Kidney Dis, 2000, 35(5): 802-811.
  • 10[7]Meier-Kriesche HU, Gitomer J, Finkel K, et al. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation [J].Crit Care Med, 2001, 29(4): 748-752.

共引文献1525

同被引文献24

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部